FINWIRES · TerminalLIVE
FINWIRES

Oppenheimer Initiates Astrana Health at Outperform With $53 Price Target

By

Astrana Health (ASTH) has an average rating of buy and mean price target of $51.50, according to analysts polled by FactSet.

What else is happening in Research?